Physicians' Academy for Cardiovascular Education

The mechanism of SGLT2 inhibition in glucose control

3' education - July 24, 2015


A mechanism of action animation of SGLT2-inhibition, a diabetes therapy that directly targets glucose by reducing renal glucose reabsorption, independently of beta cell function and insulin resistance.

Provided as an educational service by Boehringer Ingelheim - Lilly

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: